Your browser doesn't support javascript.
loading
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.
Ertesvåg, Nina Urke; Xiao, Julie; Zhou, Fan; Ljostveit, Sonja; Sandnes, Helene; Lartey, Sarah; Sævik, Marianne; Hansen, Lena; Madsen, Anders; Mohn, Kristin G I; Fjelltveit, Elisabeth; Olofsson, Jan Stefan; Tan, Tiong Kit; Rijal, Pramila; Schimanski, Lisa; Øyen, Siri; Brokstad, Karl Albert; Dunachie, Susanna; Jämsén, Anni; James, William S; Harding, Adam C; Harvala, Heli; Nguyen, Dung; Roberts, David; Zambon, Maria; Townsend, Alain; Langeland, Nina; Cox, Rebecca Jane.
Affiliation
  • Ertesvåg NU; Influenza Centre, University of Bergen, Bergen, Norway.
  • Xiao J; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
  • Zhou F; Influenza Centre, University of Bergen, Bergen, Norway.
  • Ljostveit S; Influenza Centre, University of Bergen, Bergen, Norway.
  • Sandnes H; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Lartey S; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Sævik M; Influenza Centre, University of Bergen, Bergen, Norway.
  • Hansen L; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Madsen A; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Mohn KGI; Influenza Centre, University of Bergen, Bergen, Norway.
  • Fjelltveit E; Influenza Centre, University of Bergen, Bergen, Norway.
  • Olofsson JS; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Tan TK; Influenza Centre, University of Bergen, Bergen, Norway.
  • Rijal P; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Schimanski L; Influenza Centre, University of Bergen, Bergen, Norway.
  • Øyen S; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Brokstad KA; Influenza Centre, University of Bergen, Bergen, Norway.
  • Dunachie S; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
  • Jämsén A; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
  • James WS; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
  • Harding AC; Eidsvåg Family Practice, Bergen, Norway.
  • Harvala H; Broegelmann Research Laboratory, University of Bergen, Bergen, Norway.
  • Nguyen D; Department of Safety, Chemistry and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
  • Roberts D; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Zambon M; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE UK.
  • Townsend A; Microbiology Services, NHS Blood and Transplant, Colindale, UK.
  • Langeland N; Clinical, Research and Development, NHS Blood and Transplant, Oxford, UK.
Commun Med (Lond) ; 2: 36, 2022.
Article de En | MEDLINE | ID: mdl-35603265
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Langue: En Journal: Commun Med (Lond) Année: 2022 Type de document: Article Pays d'affiliation: Norvège Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Langue: En Journal: Commun Med (Lond) Année: 2022 Type de document: Article Pays d'affiliation: Norvège Pays de publication: Royaume-Uni